331 related articles for article (PubMed ID: 35662442)
21. Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy.
Laurberg P; Bournaud C; Karmisholt J; Orgiazzi J
Eur J Endocrinol; 2009 Jan; 160(1):1-8. PubMed ID: 18849306
[TBL] [Abstract][Full Text] [Related]
22. [Role of TSH receptor autoantibodies for the diagnosis of Graves' disease and for the prediction of the course of hyperthyroidism and ophthalmopathy. Recommendations of the Thyroid Section of the German Society of Endocrinology].
Eckstein A; Mann K; Kahaly GJ; Grussendorf M; Reiners C; Feldkamp J; Quadbeck B; Bockisch A; Schott M
Med Klin (Munich); 2009 May; 104(5):343-8. PubMed ID: 19444414
[TBL] [Abstract][Full Text] [Related]
23. [Basedow's disease].
Scheidegger K
Schweiz Rundsch Med Prax; 1993 Aug; 82(32):840-4. PubMed ID: 7690495
[TBL] [Abstract][Full Text] [Related]
24. Surgical management in Graves' disease.
Thompson GB
Panminerva Med; 2002 Dec; 44(4):287-93. PubMed ID: 12434111
[TBL] [Abstract][Full Text] [Related]
25. Graves' disease: clinical pathophysiology, presentation and treatment options.
Holt K
J Pract Nurs; 2010; 60(3):13-8. PubMed ID: 21175104
[No Abstract] [Full Text] [Related]
26. Current management of thyroid-associated ophthalmopathy in Europe. Results of an international survey.
Weetman AP; Wiersinga WM
Clin Endocrinol (Oxf); 1998 Jul; 49(1):21-8. PubMed ID: 9797843
[TBL] [Abstract][Full Text] [Related]
27. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.
Bartalena L; Marcocci C; Bogazzi F; Manetti L; Tanda ML; Dell'Unto E; Bruno-Bossio G; Nardi M; Bartolomei MP; Lepri A; Rossi G; Martino E; Pinchera A
N Engl J Med; 1998 Jan; 338(2):73-8. PubMed ID: 9420337
[TBL] [Abstract][Full Text] [Related]
28. Definitive treatment of Graves' disease in children and adolescents.
Król A; Czarniecka A; Jarząb B
Endokrynol Pol; 2021; 72(6):661-665. PubMed ID: 34855196
[TBL] [Abstract][Full Text] [Related]
29. Thyrotoxicosis.
Franklyn JA; Boelaert K
Lancet; 2012 Mar; 379(9821):1155-66. PubMed ID: 22394559
[TBL] [Abstract][Full Text] [Related]
30. Primary therapy of Graves' disease and cardiovascular morbidity and mortality: a linked-record cohort study.
Okosieme OE; Taylor PN; Evans C; Thayer D; Chai A; Khan I; Draman MS; Tennant B; Geen J; Sayers A; French R; Lazarus JH; Premawardhana LD; Dayan CM
Lancet Diabetes Endocrinol; 2019 Apr; 7(4):278-287. PubMed ID: 30827829
[TBL] [Abstract][Full Text] [Related]
31. Time course of Graves' ophthalmopathy after total thyroidectomy alone or followed by radioiodine therapy: a 2-year longitudinal study.
De Bellis A; Conzo G; Cennamo G; Pane E; Bellastella G; Colella C; Iacovo AD; Paglionico VA; Sinisi AA; Wall JR; Bizzarro A; Bellastella A
Endocrine; 2012 Apr; 41(2):320-6. PubMed ID: 22169963
[TBL] [Abstract][Full Text] [Related]
32. [Graves-Basedow's disease: effect of treatment methods for hyperthyroidism on the course of ophthalmopathy].
Myśliwiec J; Grygorczuk S; Kinalska I
Pol Arch Med Wewn; 2000 Jul; 104(1):413-8. PubMed ID: 11303333
[TBL] [Abstract][Full Text] [Related]
33. The Long-Term Outcome of Treatment for Graves' Hyperthyroidism.
Sjölin G; Holmberg M; Törring O; Byström K; Khamisi S; de Laval D; Abraham-Nordling M; Calissendorff J; Lantz M; Hallengren B; Filipsson Nyström H; Wallin G
Thyroid; 2019 Nov; 29(11):1545-1557. PubMed ID: 31482765
[No Abstract] [Full Text] [Related]
34. Radioiodine therapy (RAI) for Graves' disease (GD) and the effect on ophthalmopathy: a systematic review.
Acharya SH; Avenell A; Philip S; Burr J; Bevan JS; Abraham P
Clin Endocrinol (Oxf); 2008 Dec; 69(6):943-50. PubMed ID: 18429949
[TBL] [Abstract][Full Text] [Related]
35. Chronology of Graves' ophthalmopathy in an incidence cohort.
Bartley GB; Fatourechi V; Kadrmas EF; Jacobsen SJ; Ilstrup DM; Garrity JA; Gorman CA
Am J Ophthalmol; 1996 Apr; 121(4):426-34. PubMed ID: 8604736
[TBL] [Abstract][Full Text] [Related]
36. Treatment of Graves' hyperthyroidism: evidence-based and emerging modalities.
Hegedüs L
Endocrinol Metab Clin North Am; 2009 Jun; 38(2):355-71, ix. PubMed ID: 19328416
[TBL] [Abstract][Full Text] [Related]
37. Graves' disease in clinical perspective.
Ehlers M; Schott M; Allelein S
Front Biosci (Landmark Ed); 2019 Jan; 24(1):35-47. PubMed ID: 30468646
[TBL] [Abstract][Full Text] [Related]
38. Use of radioiodine in adolescent Graves' disease.
Teelucksingh S; Singh V; Balkaran B
Ann Trop Paediatr; 2001 Dec; 21(4):335-8. PubMed ID: 11732151
[TBL] [Abstract][Full Text] [Related]
39. Controversies related to the medical and surgical management of hyperthyroidism in children.
Waldhausen JH
Semin Pediatr Surg; 1997 Aug; 6(3):121-7. PubMed ID: 9263333
[TBL] [Abstract][Full Text] [Related]
40. Graves' Disease Pharmacotherapy in Women of Reproductive Age.
Prunty JJ; Heise CD; Chaffin DG
Pharmacotherapy; 2016 Jan; 36(1):64-83. PubMed ID: 26799350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
